PIK3CA and cancer: We and others have previously shown that the phosphorylation status of 4E-BP1 and its regulated cap-dependent translation activity are linked with cancer progression and therapeutic responses in tumors such as in breast and colon cancers with mutational activation of the PI3K/AKT signaling pathway [9-13, 26-29].